ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 135 filers reported holding ARCUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 4.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,759,490 | +88279.2% | 1,602,200 | 0.0% | 1.53% | +1.5% |
| Q2 2023 | $32,541 | +24.6% | 1,602,200 | +11.9% | 1.51% | +17.6% |
| Q1 2023 | $26,123 | -99.9% | 1,432,200 | 0.0% | 1.28% | -17.8% |
| Q4 2022 | $29,617,896 | -20.9% | 1,432,200 | 0.0% | 1.56% | -25.9% |
| Q3 2022 | $37,466,000 | +3.2% | 1,432,200 | 0.0% | 2.11% | -8.4% |
| Q2 2022 | $36,292,000 | -19.7% | 1,432,200 | 0.0% | 2.30% | -1.0% |
| Q1 2022 | $45,200,000 | -22.0% | 1,432,200 | 0.0% | 2.32% | +3.2% |
| Q4 2021 | $57,961,000 | -20.3% | 1,432,200 | -31.3% | 2.25% | -11.3% |
| Q3 2021 | $72,700,000 | +27.0% | 2,084,883 | 0.0% | 2.54% | +25.7% |
| Q2 2021 | $57,251,000 | -2.2% | 2,084,883 | 0.0% | 2.02% | +1.8% |
| Q1 2021 | $58,544,000 | +8.2% | 2,084,883 | 0.0% | 1.98% | +14.1% |
| Q4 2020 | $54,124,000 | +51.5% | 2,084,883 | 0.0% | 1.74% | +40.9% |
| Q3 2020 | $35,735,000 | -30.7% | 2,084,883 | 0.0% | 1.24% | -45.5% |
| Q2 2020 | $51,580,000 | +20.5% | 2,084,883 | -32.4% | 2.27% | -22.3% |
| Q1 2020 | $42,818,000 | +153.5% | 3,084,883 | +84.5% | 2.92% | +205.5% |
| Q4 2019 | $16,890,000 | +518.7% | 1,672,233 | +457.4% | 0.96% | +382.3% |
| Q3 2019 | $2,730,000 | – | 300,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |